We are live on ! Find out more
ABG

Ally Bridge Group Portfolio holdings

AUM $124M
1-Year Est. Return 249.88%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+249.88%
3 Year Est. Return
+942.29%
5 Year Est. Return
+671.08%
10 Year Est. Return
–
AUM
$522M
AUM Growth
-$61.9M
Cap. Flow
-$46M
Cap. Flow %
-8.82%
Top 10 Hldgs %
67.45%
Holding
38
New
8
Increased
6
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
NUVB icon
Nuvation Bio
NUVB
+$22.4M
2
VRDN icon
Viridian Therapeutics
VRDN
+$12.7M
3
CVAC
CureVac
CVAC
+$10.7M
4
BOLT icon
Bolt Biotherapeutics
BOLT
+$9.36M
5
IMVT icon
Immunovant
IMVT
+$6.86M

Top Sells

Rank Stock Value
1
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$11.9M
2
CSTL icon
Castle Biosciences
CSTL
+$8.27M
3
LUNG icon
Pulmonx
LUNG
+$8.04M
4
AVIR icon
Atea Pharmaceuticals
AVIR
+$7.63M
5
VIR icon
Vir Biotechnology
VIR
+$7.37M

Sector Composition

Rank Sector Weight
1 Healthcare 77.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRY icon
26
ARS Pharmaceuticals
SPRY
$590M
$5.61M 1.08%
128,572
– –
ACET icon
27
Adicet Bio
ACET
$72.8M
$5.56M 1.07%
+26,563
New +$6.1M
FRLN
28
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$5.03M 0.96%
27,248
-1,085
-4% -$257K
IMVT icon
29
Immunovant
IMVT
$8.09B
$4.17M 0.8%
+260,000
New +$6.86M
ORTX
30
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.97M 0.76%
54,743
– –
LUNG icon
31
Pulmonx
LUNG
$49.4M
$2.7M 0.52%
58,939
-140,183
-70% -$8.04M
IDYA icon
32
IDEAYA Biosciences
IDYA
$3.41B
$705K 0.14%
+30,000
New +$579K
AUPH icon
33
Aurinia Pharmaceuticals
AUPH
$1.97B
– –
-858,032
Closed -$11.9M
SRPT icon
34
CALL
Sarepta Therapeutics
SRPT
$1.66B
– –
-238,600
Closed -$40.7M
VIR icon
35
Vir Biotechnology
VIR
$1.47B
– –
-275,000
Closed -$7.37M
NSTG
36
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-9,277
Closed -$620K
ONCT
37
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-15,000
Closed -$1.47M
KDNY
38
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-199,600
Closed -$3.17M
1
2

Similar funds

MP
Marcho Partners London, United Kingdom $124M AUM 15.03% 1-Year Est. Return
EWP
E-Wealth Partners Minnetonka, Minnesota $124M AUM
WFA
WJ Financial Advisors Killingworth, Connecticut $124M AUM
VWM
Vigil Wealth Management Ponte Vedra Beach, Florida $124M AUM
EI
EDMP Inc Lutz, Florida $124M AUM 19.53% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $124M AUM
IFO
Intrepid Family Office Sarasota, Florida $124M AUM 37.91% 1-Year Est. Return
CRW
Clarity Retirement & Wealth New Bedford, Massachusetts $124M AUM

Ally Bridge Group's Q1 2021 Portfolio in Review

As of Q1 2021, Ally Bridge Group held 38 positions worth $522M, down 11% from $584M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Ally Bridge Group withdrew a net $46M in Q1 2021, closing 6 positions and reducing 7 holdings. Its most notable exit was Aurinia Pharmaceuticals, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 65% a quarter earlier.

Against the trend, Ally Bridge Group opened a new position in Nuvation Bio worth $20.9M.

  • Ally Bridge Group's largest Q1 2021 buy was Nuvation Bio: 2,000,000 shares worth $20.9M.
  • Ally Bridge Group added most to ESSA Pharma in Q1 2021, an estimated $6.62M increase.
  • Ally Bridge Group's biggest Q1 2021 reduction was Castle Biosciences, cutting an estimated $8.27M.
  • Ally Bridge Group fully exited Aurinia Pharmaceuticals in Q1 2021, selling an estimated $11.9M.
  • Ally Bridge Group's ten largest holdings make up 67% of its $522M portfolio in Q1 2021.
  • Ally Bridge Group opened 8 new positions and closed 6 in Q1 2021.
  • Ally Bridge Group's portfolio value fell 11% quarter-over-quarter to $522M.

Based on Ally Bridge Group's 13F filing for Q1 2021, filed 17 May 2021.